The Damon Runyon Cancer Research Foundation has awarded six Clinical Investigators $4.8 million to develop new cancer treatments. The grants aim to restore immune defenses to prevent relapse and improve survival in patients with acute myeloid leukemia and other blood cancers.
The foundation named 14 new Damon Runyon Fellows, providing them with independent funding to investigate cancer causes, mechanisms, therapies, and prevention. The fellows aim to pursue breakthroughs in cancer prevention, diagnostics, and therapeutics.
The Damon Runyon Cancer Research Foundation is investing nearly $1.4 million to support three young physician-scientists with innovative ideas about cancer treatment. The awardees will receive funding and freedom to pursue research in the early stages of their careers, which has led to breakthroughs in immunotherapy and other areas.
The foundation has awarded fellowships to Minsoo Kim, Sahana Kuthyar, and Matthew Leventhal to investigate rare cell populations in healthy tissues and pneumonia risk in immunocompromised patients. They aim to develop new computational tools to understand biomarkers and microenvironmental influences.
Five fellows will receive funding for four years to study hard-to-treat pediatric cancers, reduce treatment toxicity, and develop innovative therapies. Their research focuses on Ewing sarcoma, leukemia, kidney cancer, and immune system vulnerabilities.
The foundation named 13 new Damon Runyon Fellows and six recipients of the Damon Runyon-Dale F. Frey Award for Breakthrough Scientists, awarding them a total of $4.5 million to investigate various aspects of cancer research. The awards recognize promising young scientists conducting basic and translational cancer research.
The Accelerating Cancer Cures Research Symposium brings together Damon Runyon scientists and industry partners to foster communication and collaboration. The symposium features updates on research aimed at developing more precise targeted therapies for cancer treatment.
The foundation awarded $400,000 over two years to five early-career researchers and continuation support to three current Innovators with significant progress on their proposed research. The recipients focus on developing targeted therapeutics, decoding dendritic cell function, defining NKT cell interactions with tumors, engineering T ...
The Damon Runyon Cancer Research Foundation has named the newest cohort of SPARK Scholars, providing post-baccalaureate scholars with research training, mentors, and networking opportunities. The program's recipients will conduct cancer research in top institutions and present their findings at the annual Damon Runyon Fellows' Retreat.
The foundation provides $300,000 total funding over four years to investigate cancer causes, mechanisms, therapies, and prevention. This support fosters interdisciplinary research and encourages innovative projects that push boundaries and make breakthroughs.
The Damon Runyon Cancer Research Foundation has awarded $4.2 million to five new Clinical Investigators conducting patient-oriented cancer research. The awards will support the development of new treatments for cancer patients, with a focus on enhancing efficacy and safety.
The foundation recognizes five early-career scientists who apply computational methods to cancer research, with a focus on developing new protein designs and understanding chromatin modifications. Their work aims to improve treatment strategies and precision oncology for various cancers.
The Damon Runyon Cancer Research Foundation has named 13 new Fellows, awarding them $300,000 each to investigate cancer causes and mechanisms. Five recipients of the Dale F. Frey Award for Breakthrough Scientists will also receive an additional $100,000 investment to catapult their research careers.
The Damon Runyon-St. Jude Pediatric Cancer Research Fellowship aims to address a funding gap for pediatric cancer research. The program supports innovative projects that could significantly impact the diagnosis or treatment of one or more pediatric cancers.
The foundation has awarded eight recipients of the 2025 Damon Runyon-Rachleff Innovation Award, including five early-career researchers with initial grants of $400,000 over two years. The awardees aim to develop novel cancer therapies using innovative approaches such as engineered skin bacteria and small molecule-boosted drug delivery.
The Damon Runyon Cancer Research Foundation is offering extension awards to scientists impacted by COVID-19 related laboratory shutdowns, providing up to $1,170,000 in additional funding during this fiscal year. This support aims to help promising scientists regain momentum and continue their cancer research.
The Damon Runyon Cancer Research Foundation has awarded $231,000 in funding to 16 postdoctoral scientists conducting innovative cancer research projects. The Fellowship aims to encourage promising young scientists to pursue careers in cancer research.
The Damon Runyon Cancer Research Foundation has awarded $3.5 million in fellowships to 15 early-career researchers, providing them with independence to pursue high-risk projects. The funding aims to support innovative cancer research and encourage promising young scientists to pursue careers in the field.
The Damon Runyon Cancer Research Foundation has named four outstanding young scientists as recipients of the prestigious Damon Runyon-Sohn Pediatric Cancer Fellowship Award, committing nearly $1 million to address a critical shortage of funding for pediatric cancer research. The award provides four-year funding totaling $231,000 and su...
The foundation awarded Continuation Grants to five Damon Runyon Clinical Investigators, providing an additional two years of funding totaling $400,000. The recipients are conducting patient-oriented cancer research with the goal of finding cures for cancer diagnosis, prevention and treatment.
The Damon Runyon Physician-Scientist Training Award provides physicians with research skills and experience to become leaders in translational and clinical research. The award addresses financial burdens that deter physicians from pursuing a research career, offering up to $460,000 over four years.
The foundation awarded over $4.7 million in grants to support innovative projects and breakthrough discoveries in cancer research. Young scientists will receive funding to pursue careers in cancer research and develop novel therapies.
The foundation awarded grants to nine early-career scientists working on novel approaches to fighting cancer. The recipients will receive up to four years of funding to explore their projects, which include gene editing technology CRISPR and single cell sequencing techniques.
The foundation grants four-year, $231,000 fellowships to support novel projects and encourage early career researchers in cancer science. The recipients are working on innovative projects such as developing T-cell receptors for immunotherapy and understanding protein modification in cancer development.
The foundation awarded six new Damon Runyon Clinical Investigators, who will receive $450,000 each to develop their cancer research programs. Three others received Continuation Grants totaling $300,000, supporting their ongoing research.
The Damon Runyon Cancer Research Foundation has announced five new Physician-Scientist Training Awards, which will provide $2.3 million in funding for the recipients. The awards aim to address the financial disincentives that often deter physicians from pursuing a research career.
The foundation grants nearly $4.1M to support innovative early career researchers and breakthrough scientists conducting basic and translational cancer research. The recipients receive funding to pursue novel projects, with the goal of making paradigm-shifting breakthroughs in cancer prevention, diagnosis, and treatment.
The foundation awarded grants to early career scientists with 'high-risk/high-reward' ideas who lack preliminary data, aiming to significantly impact cancer prevention, diagnosis, and treatment. The recipients will use prebiotics to manipulate the microbiota, develop novel degraders for targeted therapies, and investigate tumor T cells...
The Damon Runyon Cancer Research Foundation has awarded four young pediatric cancer researchers with nearly $1 million in funding. The award supports innovative research into prevention, diagnosis, and treatment of one or more pediatric cancers.
The Damon Runyon Cancer Research Foundation has awarded nearly $4.16M in fellowships to 18 early-career scientists conducting basic and translational cancer research. These four-year awards provide independent funding to investigate novel ideas with potential impact on cancer prevention, diagnosis, and treatment.
The Damon Runyon Cancer Research Foundation awarded $3.1M to five new Clinical Investigators and Continuation Grants to three existing recipients. The winners are conducting groundbreaking research in pancreatic cancer, glioblastoma, and leptomeningeal metastasis.
The Damon Runyon Cancer Research Foundation has awarded four physician-scientists with over $1.8 million in funding to pursue cancer research. The awards provide critical support to enhance translation and clinical research, addressing the financial disincentives that often deter physicians from pursuing a research career.
The Damon Runyon Cancer Research Foundation has awarded nearly $4 million in fellowships to 16 early-career researchers, providing them with independence to pursue innovative projects. The foundation's Breakthrough Scientist Awards also recognize three researchers who have made paradigm-shifting breakthroughs in cancer research.
The Damon Runyon-Rachleff Innovation Awards support novel approaches to fighting cancer with $2.1 million grants to nine innovative early-career scientists. Their projects aim to significantly impact cancer prevention, diagnosis, and treatment.
The Damon Runyon Cancer Research Foundation has awarded fellowships to 17 early career researchers conducting basic and translational cancer research. The four-year awards total nearly $3.95 million, providing independent funding to support novel ideas in cancer prevention, diagnosis, and treatment.
The Damon Runyon-Sohn Pediatric Cancer Research Fellowship Award provides funding to promising young scientists working on high-impact translational research. The award supports research into childhood and adolescent cancers, which often receive limited funding compared to adult cancer research.
The Damon Runyon Cancer Research Foundation has awarded over $4 million to 10 top clinical investigators to support patient-oriented cancer research. The award aims to address the shortage of physicians capable of translating scientific discovery into new breakthroughs for cancer patients.
The Damon Runyon Cancer Research Foundation has selected five physician-scientists to receive the Physician-Scientist Training Award, providing them with resources to pursue cancer research. The awardees will receive grants totaling $2.3 million to aid their work in addressing the growing need for cancer research.
The Damon Runyon Cancer Research Foundation awarded over $4.39M to 23 researchers conducting innovative cancer research, including four Breakthrough Scientists awards. These grants aim to support novel ideas and therapies in basic and translational cancer research.
Seven scientists with novel approaches to fighting cancer have been named recipients of the Damon Runyon-Rachleff Innovation Award. The grant funds cancer research by exceptionally creative thinkers with 'high-risk/high-reward' ideas, aiming to significantly impact cancer prevention, diagnosis, and treatment.
The foundation awarded four-year fellowships to 16 postdoctoral scientists conducting innovative cancer research, providing them with independent funding to work on novel projects. The recipients aim to understand cell migration, protein crowding, and gene expression in cancer cells.
The foundation named four young scientists to tackle cancers in children and young adults. The fellowship award will provide nearly $875,000 to support their research over four years.
The Damon Runyon Cancer Research Foundation has established a new award to increase the number of physician-scientists in cancer research. The grant provides $100,000 per year for three years and up to $100,000 of medical school debt repayment. Two awardees will investigate novel approaches to fighting cancer.
The Damon Runyon Cancer Research Foundation has awarded over $3.76 million in fellowships and Breakthrough Scientist awards to 15 new recipients, providing them with independent funding to pursue innovative projects. The fellows will focus on novel ideas and approaches to combat cancer.
The Damon Runyon-Rachleff Innovation Award funds novel approaches to fighting cancer, enabling exceptionally creative thinkers to develop high-risk/high-reward ideas that lack preliminary data. The awardees have the potential to significantly impact cancer prevention, diagnosis, and treatment.
The foundation has granted over $3.3 million to support the research of 16 early-career investigators pursuing novel ideas in cancer research. The recipients will focus on developing new treatments and understanding the underlying mechanisms of various types of cancers.
The foundation has committed nearly $49 million to support the careers of 77 physician-scientists across the US since 2000. The Clinical Investigator Award program aims to address the shortage of physicians capable of translating scientific discovery into new cancer breakthroughs.
The Damon Runyon Cancer Research Foundation has named three outstanding young scientists to receive the prestigious Damon Runyon-Sohn Pediatric Cancer Research Fellowship Award, committing nearly $625,000 to support pediatric cancer research. The fellows, Ly Vu, David Woessner, and Mark Zimmerman, will conduct research with the potenti...
The Damon Runyon-Rachleff Innovation Award funds groundbreaking projects that aim to prevent, diagnose, and treat cancer. This year's recipients are Emily P. Balskus, Arvin C. Dar, Summer L. Gibbs, Xiaolin Nan, Moritz F. Kircher, and Eirini Papapetrou, who will receive $450,000 over three years for their innovative ideas.
The Damon Runyon Cancer Research Foundation has awarded over $2.8 million to 20 top young scientists for their innovative cancer research projects. The award provides independent funding to early career investigators to pursue novel ideas and aims to make paradigm-shifting breakthroughs in cancer prevention, diagnosis, and treatment.